+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

XOPENEX HFA Drug Profile, 2019

  • ID: 4727201
  • Report
  • February 2020
  • Region: Global
  • 49 pages
  • thinkBiotech LLC
1 of 4

FEATURED COMPANIES

  • Actavis Pharma Inc.
  • Proficient Rx Lp
  • MORE
XOPENEX HFA Drug Profile, 2019 is part of a deep library of business intelligence on biopharmaceutical drugs.

The report focuses on XOPENEX HFA and covers the following critical aspects of this drug:
  • United States patents
  • Expired United States patents
  • District Court patent litigation
  • Clinical trials
  • Drug prices
  • Annual sales revenues
  • Finished product suppliers
About the Researcher

The researcher is a provider of global business intelligence on biologic and small-molecule drugs, dedicated to helping clients make better decisions. Critical information on global drug patents is incorporated with litigation intelligence, drug prices, and historic sales figures to help users discover commercial opportunities and forecast future revenue events. Since 2005 the researcher has served hundreds of large and small companies in more than 65 countries.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Actavis Pharma Inc.
  • Proficient Rx Lp
  • MORE
  • Profile for XOPENEX HFA
  • US Patents
  • US Regulatory Exclusivity
  • Expired US Patents
  • US District Court Litigation
  • International (ex US) Patents
  • Clinical Trials
  • Drug Prices - Average Pharmacy Cost
  • Annual Sales Revenues
  • Finished Product Suppliers
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Sunovion Pharmaceuticals Inc.
  • Actavis Pharma Inc.
  • Proficient Rx Lp
  • Preferred Pharmaceuticals Inc.
Note: Product cover images may vary from those shown
Adroll
adroll